XML 22 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
SEGMENT INFORMATION
 3 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
SEGMENT INFORMATION
6.
SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2015.
 
 
 
Three Months Ended
 
 
 
December 31,
 
 
 
2015
 
2014
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
Service
 
$
4,055
 
$
4,398
 
Product
 
 
840
 
 
1,447
 
 
 
$
4,895
 
$
5,845
 
 
 
 
 
 
 
 
 
Operating income (loss):
 
 
 
 
 
 
 
Service
 
$
(322)
 
$
18
 
Product
 
 
(207)
 
 
124
 
 
 
$
(529)
 
$
142
 
 
 
 
 
 
 
 
 
Interest Expense
 
 
(66)
 
 
(81)
 
Change in fair value of warrant liability – decrease
 
 
89
 
 
120
 
Other income
 
 
1
 
 
2
 
 
 
 
 
 
 
 
 
Income (loss) before income taxes
 
$
(505)
 
$
183